chr19-8421845-C-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001005415.2(MARCHF2):c.5C>T(p.Thr2Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000392 in 1,606,722 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00018 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )
Consequence
MARCHF2
NM_001005415.2 missense
NM_001005415.2 missense
Scores
3
6
10
Clinical Significance
Conservation
PhyloP100: 7.55
Genes affected
MARCHF2 (HGNC:28038): (membrane associated ring-CH-type finger 2) MARCH2 is a member of the MARCH family of membrane-bound E3 ubiquitin ligases (EC 6.3.2.19). MARCH enzymes add ubiquitin (see MIM 191339) to target lysines in substrate proteins, thereby signaling their vesicular transport between membrane compartments. MARCH2 reduces surface accumulation of several glycoproteins and appears to regulate early endosome-to-trans-Golgi network (TGN) trafficking (Bartee et al., 2004 [PubMed 14722266]; Nakamura et al., 2005 [PubMed 15689499]).[supplied by OMIM, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.29668826).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MARCHF2 | NM_001005415.2 | c.5C>T | p.Thr2Met | missense_variant | 2/5 | ENST00000215555.7 | NP_001005415.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MARCHF2 | ENST00000215555.7 | c.5C>T | p.Thr2Met | missense_variant | 2/5 | 5 | NM_001005415.2 | ENSP00000215555.2 |
Frequencies
GnomAD3 genomes AF: 0.000177 AC: 27AN: 152198Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
27
AN:
152198
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000369 AC: 9AN: 243970Hom.: 0 AF XY: 0.0000227 AC XY: 3AN XY: 131988
GnomAD3 exomes
AF:
AC:
9
AN:
243970
Hom.:
AF XY:
AC XY:
3
AN XY:
131988
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000248 AC: 36AN: 1454524Hom.: 0 Cov.: 30 AF XY: 0.0000221 AC XY: 16AN XY: 723136
GnomAD4 exome
AF:
AC:
36
AN:
1454524
Hom.:
Cov.:
30
AF XY:
AC XY:
16
AN XY:
723136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000177 AC: 27AN: 152198Hom.: 1 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74346
GnomAD4 genome
AF:
AC:
27
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
11
AN XY:
74346
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
1
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2024 | The c.5C>T (p.T2M) alteration is located in exon 3 (coding exon 1) of the MARCH2 gene. This alteration results from a C to T substitution at nucleotide position 5, causing the threonine (T) at amino acid position 2 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;.;.;T;.;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D;D;D;D;.
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;.;M;.;.;M
MutationTaster
Benign
D;D;D
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;.;N;.;.;.
REVEL
Benign
Sift
Pathogenic
D;.;.;D;.;.;.
Sift4G
Uncertain
D;D;D;D;D;D;D
Polyphen
P;.;.;D;.;.;D
Vest4
MutPred
Loss of catalytic residue at T2 (P = 0.001);Loss of catalytic residue at T2 (P = 0.001);Loss of catalytic residue at T2 (P = 0.001);Loss of catalytic residue at T2 (P = 0.001);Loss of catalytic residue at T2 (P = 0.001);Loss of catalytic residue at T2 (P = 0.001);Loss of catalytic residue at T2 (P = 0.001);
MVP
MPC
1.0
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at